Stock listing

KRX:397030 Aprilbio Co., Ltd. (에이프릴바이오) 주가

Follow Aprilbio Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:397030

₩12,710 KRW +1,260 (+11.0%)

Close on Nov 20, 2026

Past year -67.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩12,510 – ₩13,190 KRWNov 20, 2026
Volume
140,888 sharesNov 20, 2026
Market cap
₩297.6B KRWAt the close on Nov 20, 2026 · price × 23.41M shares outstanding
52-week range
₩10,310 – ₩76,700 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩3.87B KRWMedian day 167,840 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Aprilbio Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:397030 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩12,710+1,260+11.0%₩12,870₩13,190₩12,510140,888
₩11,450+40+0.4%₩11,570₩12,120₩11,23065,861
₩11,41000.0%₩11,110₩11,960₩11,11082,838
₩11,410-700-5.8%₩12,130₩12,310₩11,350101,999
₩12,110-40-0.3%₩12,260₩13,310₩12,070166,255
₩12,150-250-2.0%₩12,310₩12,780₩12,000124,906
₩12,400+760+6.5%₩11,500₩12,500₩11,470142,541
₩11,640+820+7.6%₩11,200₩11,740₩11,100119,844
₩10,820+120+1.1%₩10,560₩11,460₩10,380205,289
₩10,700-680-6.0%₩10,510₩10,990₩10,310198,560
₩11,380-230-2.0%₩11,810₩12,450₩11,290213,510
₩11,610+90+0.8%₩11,540₩11,670₩10,760155,633
₩11,520-340-2.9%₩11,720₩11,950₩11,330124,101
₩11,860+50+0.4%₩11,390₩12,000₩11,39073,789
₩11,810-590-4.8%₩12,210₩12,350₩11,700248,969
₩12,40000.0%₩13,110₩13,160₩12,290217,303
₩12,400+60+0.5%₩12,500₩12,900₩12,33099,930
₩12,340-60-0.5%₩12,420₩13,010₩12,34081,915
₩12,400-350-2.7%₩12,340₩12,850₩12,33056,996
₩12,750-350-2.7%₩12,730₩12,940₩12,55065,680
₩13,100-400-3.0%₩13,360₩13,560₩13,10078,318
₩13,500+300+2.3%₩13,320₩13,910₩13,32065,056
₩13,200-350-2.6%₩13,520₩13,630₩12,87081,918
₩13,550+710+5.5%₩12,300₩13,550₩12,30098,860
₩12,840+810+6.7%₩12,440₩13,220₩12,180183,012
₩12,030-880-6.8%₩12,390₩12,570₩11,810196,175
₩12,910+20+0.2%₩13,010₩13,480₩12,680156,646
₩12,890-520-3.9%₩13,060₩13,290₩12,450229,840
₩13,410-1,150-7.9%₩14,450₩14,660₩13,360253,360
₩14,560-1,190-7.6%₩15,220₩15,340₩14,510386,672
₩15,750-280-1.7%₩16,170₩16,290₩15,750237,260
₩16,030-990-5.8%₩16,440₩16,940₩15,860579,641
₩17,020-4,280-20.1%₩19,560₩19,640₩16,9251,657,247
₩21,300+1,100+5.4%₩19,980₩21,450₩19,620322,747
₩20,200+1,510+8.1%₩18,530₩20,850₩18,320459,564
₩18,690-10-0.1%₩18,510₩18,920₩17,760178,969
₩18,700+590+3.3%₩18,600₩19,540₩18,360281,259
₩18,110+310+1.7%₩17,810₩18,360₩17,72067,857
₩17,800-600-3.3%₩18,470₩18,570₩17,800113,333
₩18,400+120+0.7%₩18,200₩18,950₩18,150179,926
₩18,280+240+1.3%₩17,860₩18,370₩17,600187,265
₩18,040+360+2.0%₩17,630₩18,270₩17,550122,791
₩17,680+500+2.9%₩17,180₩17,690₩16,800111,232
₩17,180+330+2.0%₩16,800₩17,700₩16,800147,841
₩16,850-280-1.6%₩16,720₩17,360₩16,450128,267
₩17,130-120-0.7%₩16,720₩17,390₩16,720103,569
₩17,250-270-1.5%₩17,160₩17,250₩16,730101,617
₩17,520-50-0.3%₩17,480₩17,800₩17,44062,603
₩17,570-610-3.4%₩18,120₩18,410₩17,570125,059
₩18,180+380+2.1%₩17,810₩18,520₩17,460167,918
₩17,800+1,030+6.1%₩17,270₩17,970₩17,150208,197
₩16,770-350-2.0%₩17,160₩17,300₩16,600199,522
₩17,120-900-5.0%₩17,480₩17,970₩17,110167,762
₩18,020+110+0.6%₩17,750₩18,490₩17,650191,781
₩17,910-640-3.5%₩18,190₩18,190₩17,030763,903
₩18,550-720-3.7%₩19,210₩19,410₩18,410314,015
₩19,270+80+0.4%₩19,000₩19,660₩18,930252,748
₩19,190-280-1.4%₩19,650₩19,940₩19,050263,698
₩19,470-470-2.4%₩19,570₩19,690₩18,470267,065
₩19,940+100+0.5%₩20,050₩20,400₩19,590285,215
₩19,840-1,410-6.6%₩20,950₩21,100₩19,130569,969
₩21,250-5,050-19.2%₩22,900₩23,200₩20,7001,205,024

Splits

1 split · KRX:397030 · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
Ticker
KRX:397030
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Aprilbio Co., Ltd. news

Aprilbio Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 1 in all · newest Jun 25, 2026 · oldest 2026

Valuation

Price/book 3.1× against a median of 1.3×: 7th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩216.9B KRW
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
3.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Aprilbio Co., Ltd. · KRX:397030US$221.1MUS$161.1Mn/an/an/a3.1×n/a0.0×n/a
Enanta Pharmaceuticals, Inc. · NASDAQ:ENTAUS$222.2MUS$82.43Mn/a1.3×n/a2.8×−108.3%0.7×1.11
Clover Biopharmaceuticals Ltd. · HKEX:2197US$222.0MUS$206.5Mn/a403×n/an/an/an/an/a
Northwest Biotherapeutics, Inc. · OTC:NWBOUS$220.0MUS$283.8Mn/a99.4×n/an/an/an/a0.90
Keros Therapeutics, Inc. · NASDAQ:KROSUS$219.7M−US$24.67Mn/a−0.6×n/a0.8×−152.7%0.1×1.16
Immuneering Corporation · NASDAQ:IMRXUS$218.7MUS$160.5Mn/an/an/a1.3×n/a0.0×1.17
Allogene Therapeutics, Inc. · NASDAQ:ALLOUS$217.5M−US$7.44Mn/a−1.6×n/a0.6×n/a0.2×1.93
ProKidney Corp. · NASDAQ:PROKUS$217.3MUS$77.56Mn/a100×n/an/an/an/a1.61
Pyxis Oncology, Inc. · NASDAQ:PYXSUS$216.5MUS$160.9Mn/an/an/a5.2×n/a0.0×0.89
Oryzon Genomics SA · BME:ORYUS$216.4MUS$206.7Mn/an/an/a1.6×n/a0.1×n/a
Rocket Pharmaceuticals, Inc. · NASDAQ:RCKTUS$214.1M−US$25.02Mn/an/an/a0.7×n/a0.1×1.72
Median of the othersUS$218.1MUS$121.4M50.3×1.3×−130.5%0.1×1.17

Forecasts

Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.

Price target
100000.00 KRW · Analysts' mean
EPS, year to Dec 2026
-1188.00 · 1 analyst
Revenue, year to Dec 2026
13B · 1 analyst

Team and board

OfficerRole
Sanghoon ChaChief Executive Officer
Byungung HurDirector, R&D Center
Jaekyu HanDirector, R&D Center
Susan ChiManaging Director, R&D Center

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue2.17B27.5B0200.0M23.4B150.0M
Gross profit2.17B27.5B200.0M23.4B150.0M
Research and development4.02B3.20B8.04B6.92B13.9B6.78B
Selling, general and administrative754.7M6.73B4.68B4.16B1.39B378.0M
Operating income-7.26B16.7B-13.4B-11.5B4.45B-9.19B
Depreciation and amortization689.6M705.6M674.4M593.4M487.3M361.4M
EBITDA-6.57B17.5B-12.7B-10.9B4.93B-8.83B
Interest expense618.9M1.42B930.5M29.8M2.11B1.28B
Income before tax-9.73B20.0B-14.1B-8.96B-52.7B-10.3B
Net income-9.73B20.0B-14.1B-8.96B-52.7B-10.2B
Earnings per share, basic-419.16891.67-654.93-424.17-2,506.63-487.79

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents7.07B3.35B6.59B7.28B24.4B10.1B
Short-term investments85.7B91.1B57.0B61.5B30.0B7.00B
Receivables1.47B480.0M255.8M4.29B51.4M
Current assets94.7B96.6B66.7B69.4B59.4B18.0B
Property, plant and equipment1.20B1.34B1.34B
Total assets97.1B99.6B79.7B71.1B61.4B19.4B
Current liabilities541.5M8.48B21.7B1.79B4.05B33.1B
Total liabilities803.8M8.61B22.0B1.90B4.21B33.2B
Shareholders' equity96.3B91.0B57.7B69.2B57.2B-13.8B
Shares outstanding23.2M22.4M21.6M21.1M21.0M21.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-3.34B22.0B-10.1B-6.70B3.25B-7.33B
Capital spending-287.8M-445.3M-512.0M-89.6M-705.8M-479.8M
Free cash flow-3.63B21.5B-10.6B-6.79B2.55B-7.81B
Cash from investing-22.8B-7.05B-31.6B
Cash from financing-2.51B16.3B20.3B
Share buybacks1.10B1.76B20.6B
Change in cash3.73B-3.24B-697.3M-17.1B14.2B3.51B

Open Financials

Cap table

Built by 6ix from Aprilbio Co., Ltd.’s releases

Common shares
23,413,826
Fully diluted
23,413,826

Fully diluted

LineShares
Common shares23,413,826

Share count over time

CountShares
Nov 22, 202623,413,826

Open Cap table

Shareholders

Big stakes

StakeFiling
차상훈Large holding report (5%)

Open Shareholders

Log in to ask 6ix AI your own questions about Aprilbio Co., Ltd.